2017 Johns Hopkins graduate Bailey Surtees and a team of student engineers recently published a paper in ‘PLOS One’ about a device they developed that treats cancer by freezing cancerous tissue using CO2.
Scientists at Johns Hopkins University report the creation of a specialized gel that acts like a lymph node to successfully activate and multiply cancer-fighting immune system T-cells.
A new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether they’ll respond to radiation treatment, before treatment even begins.
HYPER-Melt device analyzes small volumes of fluids, detecting genetic and epigenetic changes more efficiently and cost-effectively than other devices currently on the market.
Denis Wirtz, vice provost for research, says unifying the field of cell mechanics around a common set of approaches will make it more valuable to the larger cancer research community.
The microRNAs target brain cancer stem cells to halt their capacity to propagate and sustain tumor growth.
Scientists at Johns Hopkins create approach that distills complex biomolecular data into labels that are easier to interpret.
Rong Li will lead a team of biomedical engineers, geneticists, and cancer biologists from across the U.S. and the U.K. to explore the link between inflammation and these genomic abnormalities in cancer.
With National Cancer Institute grant, Johns Hopkins researchers merge biology with applied mathematics.
The award will support Barman’s work in developing and deploying a plasmon-enhanced spectroscopic platform, which could ultimately lead to new insights into the growth and spread of diseases such as metastatic cancer.